JFS Wealth Advisors’s TG Therapeutics TGTX Stock Holding History

JFS Wealth Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1K	Buy	+20	New	+$819	﹤0.01%	1778
2026 Q1	–	Sell	-22	Closed	-$656	–	1947
2025 Q4	$656	Buy	22 +5	+29%	+$163	﹤0.01%	1764
2025 Q3	$615	Hold	17	–	–	﹤0.01%	1726
2025 Q2	$612	Hold	17	–	–	﹤0.01%	1660
2025 Q1	$671	Sell	17 -9	-35%	-$303	﹤0.01%	1728
2024 Q4	$783	Buy	+26	New	+$746	﹤0.01%	1715

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

JFS Wealth Advisors's TGTX Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in TG Therapeutics (TGTX) in Q2 2026: 20 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #1778 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in TGTX as recently as Q4 2025.

JFS Wealth Advisors first reported a position in TGTX in Q4 2024 and has held it in 6 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

JFS Wealth Advisors held 20 shares of TG Therapeutics worth $1.1K as of Q2 2026.
TG Therapeutics was a new JFS Wealth Advisors position in Q2 2026.
TG Therapeutics made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1778 holding.
JFS Wealth Advisors first reported a position in TG Therapeutics in Q4 2024 and has held it in 6 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.